Happel David
SEC insider (Form 3/4/5 filer). CIK 0001623567. President & CEO at Sagimet Biosciences Inc. (SGMT). 6 reported Form 4/5 transactions since Sep 2024; latest on Jul 20, 2026. Located in FOSTER CITY, CA.
Companies Happel David has filed insider reports for
- Sagimet Biosciences Inc. (SGMT): Director, Officer, President & CEO
Happel David
CIK: 0001623567
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Sagimet Biosciences Inc.
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Jul 20, 2026SGMT
Sagimet Biosciences Inc.
SaleDirect64.1K shares at avg. $7.76$497K - May 28, 2026SGMT
Sagimet Biosciences Inc.
AwardDirectStock Option (Right to Buy)
300K shares- - Feb 19, 2026SGMT
Sagimet Biosciences Inc.
AwardDirect128K shares- - Feb 10, 2026SGMT
Sagimet Biosciences Inc.
SaleDirect12.1K shares at avg. $5.36$65K - Jul 21, 2025SGMT
Sagimet Biosciences Inc.
SaleDirect65.5K shares at avg. $9.13$598K - Feb 6, 2025SGMT
Sagimet Biosciences Inc.
AwardDirect116K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 20, 2026 | SGMT Sagimet Biosciences Inc. | Sale | 64,051 | $7.76 | $497,068 | Direct |
| May 28, 2026 | SGMT Sagimet Biosciences Inc. | Award Stock Option (Right to Buy) | 300,000 | - | - | Direct |
| Feb 19, 2026 | SGMT Sagimet Biosciences Inc. | Award | 128,000 | - | $0 | Direct |
| Feb 10, 2026 | SGMT Sagimet Biosciences Inc. | Sale | 12,101 | $5.36 | $64,865 | Direct |
| Jul 21, 2025 | SGMT Sagimet Biosciences Inc. | Sale | 65,478 | $9.13 | $598,115 | Direct |
| Feb 6, 2025 | SGMT Sagimet Biosciences Inc. | Award | 116,000 | - | - | Direct |
1-6 of 6 transactions